e-SPACE Cardio-Renal-Metabolic 2023

Published: 25 March 2023

  • Views:

    Views Icon 11730
  • Likes:

    Heart Icon 7
  • episode_image
    58m 8s
    Part 1 | Session 1 Plenary session 1 – HFpEF Andrew JS Coats, Giuseppe Rosano, Eberhard Standl, María José Soler, Stefan Anker
Average (ratings)
No ratings
Your rating

Overview

e-SPACE Cardio-Renal-Metabolic 2023 was the third edition of the annual global online conference that explores how leading experts, in cardiology, nephrology, and diabetology, are treating the interrelated diseases.

 

Course leadership Prof Stefan Anker (Berlin, DE), Dr Javed Butler (Texas, US), Prof Antonio Ceriello (Milan, IT), Prof Tara I Chang (California, US), Prof Ian de Boer (Washington, US), Prof Peter Rossing (Copenhagen, DK) and Prof Shelley Zieroth (Winnipeg, CA) lead an interactive programme of plenary sessions, meet the expert, case discussions and satellite symposium sessions focusing on the patient journey.

 

For the first time, e-SPACE Cardio-Renal-Metabolic 2023 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.


 

e-SPACE Cardio-Renal-Metabolic 2023 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality, and reduced quality of life affecting individuals around the world
  • Describe the complexity and interlink between the three conditions
  • Discuss existing guidelines and best approaches for screening patients
  • Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
  • Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes

Target Audience

  • Cardiologists
  • Nephrologists
  • Diabetologists
  • General Practitioners (GPs)
  • HF Specialists
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Faculty Biographies

Nisha Bansal

Nisha Bansal

Associate Professor

Dr Nisha Bansal is an Associate Professor and the Arthur Stach Family Endowed Professor in the Division of Nephrology at University of Washington, Washington, US.

She completed her medical degree at the University of Connecticut, and her Master’s Degree in Clinical Research at the University of California San Francisco (UCSF).

Dr Bansal’s expertise is in hypertension and the intersection of kidney and heart disease. 

 

View full profile
Christopher Wilcox

Christopher Wilcox

Nephrologist

Prof Christopher Wilcox is a Nephrologist at Georgetown University, Washington D.C., US.

He graduated with his medical degree from Oxford University and completed his Doctor of Philosophy degree (PhD) in kidney physiology and hypertension from London University, and was later appointed a Professor of Medicine at the same educational venue, as well as at Cambridge University.

Prof Wilcox's special interests include secondary forms of hypertension (including renovascular hypertension, adrenal hypertension, and hypertension complicating kidney disease), management of complicated and drug-resistant hypertension, and renal disease.

 

View full profile
Wilfried Mullens

Wilfried Mullens

Heart Failure Clinician

Prof Wilfried Mullens is a heart failure clinician with a strong commitment to translational research translating new mechanistic insights into answering questions of clinical interest. He has been president of the Belgian Working Group on Heart Failure and serving as board member of European Heart Failure Association (HFA) leading the committee on cardiac devices.

View full profile
Areef Ishani

Areef Ishani

Nephrologist

Dr Areef Ishani is a Nephrologist and Director of the Primary and Specialty Care Service Line at Minneapolis VA Health Care System, Minneapolis, MN, US.

His areas of expertise are chronic kidney disease, end-stage renal disease, high potassium level, small lymphocytic lymphoma, and kidney transplant.

 

View full profile
William T Abraham

William T Abraham

Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine

Prof Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years.

His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve stimulation, cardiac contractility modulation, baroreflex activation therapy, and mitral valve repair.

Prof Abraham has authored more than 1,000 original works and has been named a Clarivate Analytics Highly Cited Researcher and one of The World’s Most Influential Scientific Minds.

He received the 2017 Distinguished Scientist Award from the American College of Cardiology.

With his permission, Prof Abraham is contactable here.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.